ClearPoint Neuro, Inc.CLPTNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P28
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -6.23% |
| Q3 2025 | -9.85% |
| Q2 2025 | 13.32% |
| Q1 2025 | 1.41% |
| Q4 2024 | 0.51% |
| Q3 2024 | 6.25% |
| Q2 2024 | 18.86% |
| Q1 2024 | -1.02% |
| Q4 2023 | 9.18% |
| Q3 2023 | -32.62% |
| Q2 2023 | 19.25% |
| Q1 2023 | -16.58% |
| Q4 2022 | 36.55% |
| Q3 2022 | 10.08% |
| Q2 2022 | -16.89% |
| Q1 2022 | 6.11% |
| Q4 2021 | 5.11% |
| Q3 2021 | 22.52% |
| Q2 2021 | 35.83% |
| Q1 2021 | -14.36% |
| Q4 2020 | 59.68% |
| Q3 2020 | 40.76% |
| Q2 2020 | -0.73% |
| Q1 2020 | -6.84% |
| Q4 2019 | 15.25% |
| Q3 2019 | 9.18% |
| Q2 2019 | 19.38% |
| Q1 2019 | 21.45% |
| Q4 2018 | -22.03% |
| Q3 2018 | -7.23% |
| Q2 2018 | 21.78% |
| Q1 2018 | -6.15% |
| Q4 2017 | -1.28% |
| Q3 2017 | -45.61% |
| Q2 2017 | 94.41% |
| Q1 2017 | 5.28% |
| Q4 2016 | -23.38% |
| Q3 2016 | -7.82% |
| Q2 2016 | 14.11% |
| Q1 2016 | 25.75% |